- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial primary completion date: THERMALGI: Evaluation of Spa Therapy in the Treatment of Fibromyalgia (clinicaltrials.gov) - Jan 11, 2019 P=N/A, N=220, Completed, Recruiting --> Completed | Trial completion date: Feb 2017 --> Jul 2017 | Trial primary completion date: Aug 2016 --> Jul 2017 Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Mar 2018
- |||||||||| esreboxetine (AXS-14) / Axsome Therap, Pfizer
Enrollment change: Maintenance of Efficacy. (clinicaltrials.gov) - Nov 29, 2018 P3, N=0, Withdrawn, Recruiting --> Completed N=650 --> 0
- |||||||||| NN1213 / Novo Nordisk
Trial completion: Biobehavioral Pain Management in TMD (clinicaltrials.gov) - Jul 19, 2018 P=N/A, N=300, Completed, N=650 --> 0 Recruiting --> Completed
- |||||||||| NN1213 / Novo Nordisk
Trial completion: BEMER in the Treatment of Pain in Fibromyalgia. (clinicaltrials.gov) - Jun 13, 2018 P=N/A, N=110, Completed, Trial completion date: Jan 2015 --> Dec 2018 | Trial primary completion date: Dec 2014 --> Mar 2018 Enrolling by invitation --> Completed
- |||||||||| Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date: FIBROPATHIC: Osteopathic Medicine in Fibromyalgia Syndrome (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=101, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=150 --> 101 | Trial completion date: Apr 2018 --> Aug 2018 | Trial primary completion date: Nov 2017 --> Aug 2018
- |||||||||| Trial completion, Trial primary completion date: Acute Effects of Exercise in Women With Fibromyalgia (FM) (clinicaltrials.gov) - Feb 5, 2018
P=N/A, N=55, Completed, Recruiting --> Active, not recruiting | N=150 --> 101 | Trial completion date: Apr 2018 --> Aug 2018 | Trial primary completion date: Nov 2017 --> Aug 2018 Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Nov 2012
- |||||||||| Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Enrollment change, Trial withdrawal: Botox for Treatment of TMJ Disorder With Bruxism (clinicaltrials.gov) - Jan 23, 2018 P1, N=0, Withdrawn, Active, not recruiting --> Completed N=32 --> 0 | Not yet recruiting --> Withdrawn
- |||||||||| Trial primary completion date: Biobehavioral Pain Management in TMD (clinicaltrials.gov) - Aug 9, 2017
P=N/A, N=300, Recruiting, Recruiting --> Completed Trial primary completion date: Dec 2016 --> Apr 2018
- |||||||||| NN1213 / Novo Nordisk
Phase classification: Brief Treatment for Temporomandibular Pain (clinicaltrials.gov) - Aug 1, 2017 P=N/A, N=116, Completed, Trial primary completion date: Dec 2016 --> Apr 2018 Phase classification: P1/2 --> P=N/A
- |||||||||| Trial primary completion date: The Effect of Tai Chi in Treating Fibromyalgia (clinicaltrials.gov) - Apr 4, 2017
P=N/A, N=120, Enrolling by invitation, Recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jan 2017 Trial primary completion date: Dec 2016 --> Dec 2022
- |||||||||| Trial completion, Trial primary completion date: The Pathogenesis of Idiopathic Dry Eyes (clinicaltrials.gov) - Mar 15, 2017
P=N/A, N=90, Completed, Phase classification: P3 --> P=N/A Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Dec 2015
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Mindfulness Interventions and Chronic Widespread Pain in Adolescents (clinicaltrials.gov) - Mar 3, 2017
P=N/A, N=29, Completed, Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Dec 2015 Recruiting --> Completed | N=24 --> 29 | Trial primary completion date: Dec 2017 --> Dec 2016
- |||||||||| triamcinolone acetonide / Generic mfg.
Enrollment change, Trial termination: Using Saline for Myofascial Pain Syndromes (USAMPS) (clinicaltrials.gov) - Nov 8, 2016 P4, N=51, Terminated, Trial primary completion date: Nov 2016 --> Dec 2017 N=102 --> 51 | Active, not recruiting --> Terminated; lack of activity, Primary researcher moved to another institution
- |||||||||| Trial completion, Enrollment change: Neurodynamic Intervention in Fibromyalgia (clinicaltrials.gov) - Oct 28, 2016
P=N/A, N=48, Completed, N=102 --> 51 | Active, not recruiting --> Terminated; lack of activity, Primary researcher moved to another institution Recruiting --> Completed | N=70 --> 48
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: ORION: Optimizing Resilience In Orofacial Pain and Nociception (clinicaltrials.gov) - Aug 4, 2016
P=N/A, N=36, Completed, Enrolling by invitation --> Completed | Trial primary completion date: Oct 2012 --> Jan 2014 Recruiting --> Completed | N=50 --> 36 | Trial primary completion date: May 2016 --> Dec 2015
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Qigong Exercise May Benefit Patients With Fibromyalgia (clinicaltrials.gov) - Jul 5, 2016
P=N/A, N=35, Completed, Not yet recruiting --> Recruiting Recruiting --> Completed | N=80 --> 35 | Trial primary completion date: Jul 2012 --> Feb 2015
- |||||||||| Savella (milnacipran) / AbbVie, Pierre Fabre
Phase classification: The Effect of Milnacipran in Patients With Fibromyalgia (clinicaltrials.gov) - Jun 30, 2016 P2/3, N=37, Completed, Recruiting --> Completed | N=80 --> 35 | Trial primary completion date: Jul 2012 --> Feb 2015 Phase classification: P2 --> P2/3
|